- Hospitalized male or female patients greater than or equal to 18 years of age.
- Patients must be a candidate for or have had a laparotomy, or laparoscopy of an
- Patients with a complicated intra-abdominal infection such as:
- an intra-abdominal abscess;
- an intra-abdominal abscess (including liver and spleen) that develops in a
post-operative patient after receiving > 48 hours and less than or equal to 5
days of a non-study antibiotic. An intra-abdominal culture must be obtained from
the infected site.
- appendicitis complicated by perforation (grossly visible) and abscess and/or
- perforated diverticulitis complicated by abscess formation or fecal
- complicated cholecystitis with evidence of perforation or empyema;
- perforation of the large or small intestine with abscess, or fecal contamination;
- purulent peritonitis or peritonitis associated with fecal contamination;
- gastric or duodenal ulcer perforation with symptoms lasting at least 24 hours
prior to operation;
- traumatic bowel perforation with symptoms lasting at least 12 hours prior to
- Patients with any concomitant condition that, in the opinion of the investigator,
would preclude an evaluation of a response or make it unlikely that the contemplated
course of therapy or follow-up visits could be completed.
- Active or treated leukemia or systemic malignancy that required treatment with
chemotherapy, immunotherapy, radiation therapy or antineoplastic therapy within the
past 3 months, or any metastatic malignancy to the abdomen with life expectancy less
than 6 months.
- Anticipated length of antibiotic therapy less than 5 days.